Pharma company shares surge on favourable Q2 report

Valeant-Pharmaceuticals-shares-TSX-profit-revenue-acqusistions-Bausch-Lomb-Salix-EDIWeekly

Shares in Quebec’s Valeant Pharmaceuticals International surged on the Toronto Stock Exchange yesterday after the company released its second quarter earnings report, which surpassed expectations. Shares were trading at $341 per share, giving the company a value of $116 billion. This makes it, at least temporarily, the most valuable company in Canada, ahead of the Royal Bank of Canada at $106 billion. Valeant’s shares have advanced 105 per cent this year. Earlier this year its value passed two other big banks, TD in May and Scotia Bank in February. Valeant is forecasting earnings per share to reach $11.50–$11.80 and revenues of up to $11.1 billion for 2015.

The company has had greater than 15 per cent organic growth—growth in output and increased sales—in four consecutive quarters. In the latest quarter, organic growth was up 19 per cent. Valeant CEO Michael Pearson is “certain” that double-digit organic growth will continue until the end of 2016. Total revenue for the second quarter was $2.7 billion, an increase of 34 per cent over last year. Even a $173-million loss on foreign exchange had barely any effect on the company’s bottom line.

Valeant has also pursued an aggressive mergers and acquisitions strategy in recent years. Earlier this year the company acquired the specialist American firm Salix Pharmaceuticals Ltd. for $11.1 billion. Salix develops drugs and medical devices for treating gastrointestinal disorders. Its latest drug, Xifaxan, is for irritable bowel syndrome and was approved by the Food and Drug Administration in May.

Valeant also acquired eye care giant Bausch and Lomb of Rochester, New York, in May, 2013, for $8.57 billion. Other recent acquisitions include Medicis Pharmaceuticals, Solta Medical and Dendreon. Valeant has just announced that it intends to acquire Amoun, an Egyptian pharmaceutical company, for US $800 million. This will help Valeant expand in the Middle East and North Africa. The company also wants to expand in Latin America.

According to CBC news, only a few non-financial firms have held the top spot on the TSX’s market capitalization ranking. These included the once powerful telecom giant Nortel, smartphone maker Blackberry (formerly RIM), the energy company Encana, and fertilizer company PotashCorp.

Most market analysts are rating Valeant stock as “buy” or “hold,” according to Bloomberg. The company’s business is not expected to slow any time soon. Health care stocks in general have outperformed all others on the TSX over the past year, up 118 per cent.

Did you miss this?

Other Popular Stories

  • Talk of recovery in Canada's oilpatch as Encana posts better than expected earnings
  • Canada-EU free trade deal in jeopardy over investor protection
  • NASA Keeping an Eye on Tesla Roadster
  • Long March 3B rocket launch destroys home as lower rocket booster crashes during launch
  • First wearable real-time translator device could change how we do business internationally
  • Clean freight: with over 10 per cent of emissions coming from "goods moving" the push is on for greener trucking
  • Car Tech Trends from CES 2018
  • Corporate profits up 8.8 per cent over last year: Statistics Canada
  • Civil Engineering Design: What it Takes to Engineer the World’s Longest Tunnels
  • Long-term growth in residential construction centred in GTA
  • GTA food and beverage manufacturers launch Cluster to spur growth
  • Government renews $81 million contract with MacDonald Dettwiler for space work
  • Stronger concrete made from recycled tires developed by UBC Engineers: could help reduce carbon footprint of 3 billion tires-a-year
  • NASA says human Mars landing is feasible by 2030s
  • Youth trainee program seeks to address skilled labour shortage
  • Audi Recall Announced Due to Emissions
  • Bombardier to build MRO facility in China
  • Local Ford union rebellion over GM contract threatens pattern bargaining
  • Hyundai Plans to Sell Millions of BEVs
  • Oilsands companies hope to innovate cleaner, more profitable future
Scroll to Top